Morganella is a topic covered in the Johns Hopkins Antibiotic (ABX) Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~


  • Facultative anaerobic Gram-negative rod.
    • Non-lactose fermenter in the same family as Proteus.
    • Environmentally ubiquitous, part of normal colonic flora.
    • "Urea splitter," but stones seen less frequently than Proteus due to less effective urease enzyme.
  • Morganella only has single member in its genus M. morganii, and two subspecies: M. morganii and M. sibonii, which differ only in trehalose fermentation.
  • Antimicrobial susceptibility:
    • Naturally resistant to penicillin, first-, second-generation cephalosporins, macrolides, sulfamethoxazole.
    • Beta-lactamase is inducible, chromosomal AmpC type.
    • Production of extended spectrum beta-lactamases, including carbapenemases Amber class B -such as New Delhi metallo-β-lactamase 1 (NDM-1)- and Amber class D -such as OXA-181- as well as fluoroquinolone resistance have been reported
    • Tigecycline not reliably effective due to ArcAB efflux pump, although may show synergy in vitro with other antimicrobials [6].

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: April 5, 2016